Medline (MDLN) Receivables (2024 - 2026)

Medline (MDLN) has 3 years of Receivables data on file, last reported at $3.7 billion in Q1 2026.

• Receivables for Q1 2026 came in at $3.7 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (changed N/A YoY), and the FY2025 annual result was $3.5 billion, up 9.75% from the prior year.
• Receivables improved to $3.7 billion in Q1 2026 per MDLN's latest filing, from $3.5 billion in the prior quarter.
• Over five years, Receivables peaked at $3.7 billion in Q1 2026 and troughed at $3.2 billion in Q4 2024.
• A 3-year average of $3.5 billion and a median of $3.5 billion in 2025 frame the typical range for Receivables.
• On a YoY basis, Receivables climbed as much as 9.75% in 2025 and fell as far as 9.75% in 2025.
• A 3-year view of Receivables shows it stood at $3.2 billion in 2024, then increased by 9.75% to $3.5 billion in 2025, then rose by 3.99% to $3.7 billion in 2026.
• Business Quant data shows MDLN's Receivables at $3.7 billion in Q1 2026, $3.5 billion in Q4 2025, and $3.2 billion in Q4 2024.